Skip to main content
. 2015 Apr 17;2(6):699–706. doi: 10.1002/acn3.200

Figure 5.

Figure 5

Quantitation of caspase 3 and phospho-mTOR (pSer2448) levels in VGB-treated mice. Animals received VGB (35 mg/kg) using three successive i.p. administrations over a 24 h period. Caspase 3 activity is a direct measure of the mammalian apoptosis pathway, while phospho-mTOR level indicates the increased activation of the PI-3 kinase pathway and activational status of mTOR. *P < 0.05, unpaired one-tailed t test, which was employed since we predicted enhanced apoptosis and phospho-mTOR production. See Figure2 legend for x-axis details. mTOR, mechanistic target of rapamycin; VGB, vigabatrin.